• Contact Us
    •

    Resource Center

    Mar 5, 2019
      |  Flyer

    NAFLDsym® Flyer

    Keywords: Non-alcoholic fatty liver disease (NAFLD)Software: NAFLDsym®Division: DILIsym Services

    NAFLDsym® is Quantitative Systems Pharmacology (QSP) Software Capable of Exploring and Predicting Efficacy for Novel NASH Treatments.

    Click Here to View

    Contact Us About This Flyer

    Similar Resources

    Simulations Plus Press Release
    11/18/2021
    Simulations Plus Presented Breakthrough Scientific Data at Top Liver Disease Conference
    Keywords: fibrosis, NAFLDsym, NASH, Non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), yo-yo dietingSoftware: NAFLDsym®Division: DILIsym Services
    Read More
    Simulations Plus Poster
    10/17/2021
    Predicting the Efficacy of Obeticholic Acid Treatment for Non-Alcoholic Steatohepatitis (NASH) Using NAFLDsym, a Quantitative Systems Pharmacology Model of Non-Alcoholic Fatty Liver Disease
    Woodhead JL, Yang K, Singh FA, Schmidt BJ, Siler SQ, Generaux GT
    Keywords: farnesoid X receptor (FXR), FGF19, NAFLDsym, NASH, Non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), obeticholic acid (OCA), PBPK modeling, quantitative systems pharmacology (QSP)Software: NAFLDsym®Conference: AAPSDivision: DILIsym Services
    Read More Click Here to View
    Simulations Plus Journal Article
    06/17/2021
    Quantitative Systems Pharmacology Modeling of Fibrotic Diseases
    Hamzavi N
    Keywords: drug development, IPF, IPFsym, NAFLDsym, NASH, Non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), qspSoftware: DILIsym®, NAFLDsym®Conference: SMBDivision: DILIsym Services
    Read More Click Here to View